Follow
Nikolai Petrovsky
Nikolai Petrovsky
Professor, Australian Respiratory and Sleep Medicine Research Institute
Verified email at flinders.edu.au
Title
Cited by
Cited by
Year
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
TF ADVANCE Collaborative Group, Patel A, MacMahon S
New England Journal of Medicine 358 (24), 2560-72, 2008
97722008
The transcriptional landscape of the mammalian genome
P Carninci, T Kasukawa, S Katayama, J Gough, MC Frith, N Maeda, ...
science 309 (5740), 1559-1563, 2005
40632005
Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs
RIKEN Genome Exploration Research Group Phase I Team: Carninci P. 2 Hayatsu ...
Nature 420 (6915), 563-573, 2002
21182002
Vaccine adjuvants: current state and future trends
N Petrovsky, JC Aguilar
Immunology and cell biology 82 (5), 488-496, 2004
13052004
The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line
Nature genetics 41 (5), 553-562, 2009
4182009
Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications
N Petrovsky, P McNair, LC Harrison
Cytokine 10 (4), 307-312, 1998
3901998
Inulin-a versatile polysaccharide with multiple pharmaceutical and food chemical uses
T Barclay, M Ginic-Markovic, P Cooper, N Petrovsky
Journal of Excipients and Food Chemicals 1 (3), 2016
3802016
Will blockchain technology revolutionize excipient supply chain management?
S Apte, N Petrovsky
Journal of Excipients and Food Chemicals 7 (3), 76-78, 2016
3672016
Technologies for enhanced efficacy of DNA vaccines
F Saade, N Petrovsky
Expert review of vaccines 11 (2), 189-209, 2012
3672012
Molecular mechanisms for enhanced DNA vaccine immunogenicity
L Li, N Petrovsky
Expert review of vaccines 15 (3), 313-329, 2016
3202016
Comparative safety of vaccine adjuvants: a summary of current evidence and future needs
N Petrovsky
Drug safety 38 (11), 1059-1074, 2015
3122015
The chronobiology of human cytokine production
N Petrovsky, LC Harrison
Cytokines and Cytokine Receptors, 810-824, 2001
2862001
Review of polysaccharide particle-based functional drug delivery
TG Barclay, CM Day, N Petrovsky, S Garg
Carbohydrate polymers 221, 94-112, 2019
2822019
Towards a unified model of neuroendocrine–immune interaction
N Petrovsky
Immunology and cell biology 79 (4), 350-357, 2001
2682001
The future of human DNA vaccines
L Li, F Saade, N Petrovsky
Journal of biotechnology 162 (2-3), 171-182, 2012
2522012
Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic …
Y Honda-Okubo, D Barnard, CH Ong, BH Peng, CTK Tseng, N Petrovsky
Journal of virology 89 (6), 2995-3007, 2015
2252015
Diurnal rhythmicity of human cytokine production: a dynamic disequilibrium in T helper cell type 1/T helper cell type 2 balance?
N Petrovsky, LC Harrison
Journal of immunology (Baltimore, Md.: 1950) 158 (11), 5163-5168, 1997
2221997
Computational methods for prediction of T-cell epitopes—a framework for modelling, testing, and applications
V Brusic, VB Bajic, N Petrovsky
Methods 34 (4), 436-443, 2004
2212004
Methods for prediction of peptide binding to MHC molecules: a comparative study
K Yu, N Petrovsky, C Schönbach, JLY Koh, V Brusic
Molecular medicine 8, 137-148, 2002
1932002
Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses
Y Honda-Okubo, F Saade, N Petrovsky
Vaccine 30 (36), 5373-5381, 2012
1822012
The system can't perform the operation now. Try again later.
Articles 1–20